Merck and Sanofi are the latest drugmakers to join TrumpRx.gov, offering steep discounts on diabetes, tuberculosis and blood ...

Merck (MRK) closed at $120.15 in the latest trading session, marking a -1.05% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 1.02%. Elsewhere, the Dow saw an ...

The Cancer Calculus, coordinated by the International Consortium of Investigative Journalists with Deutsche Welle and 46 ...

Merck & Co. is rounding out its March deal flurry with an antibody discovery pact that could be worth as much as $838 million ...

Some of the philanthropic foundations that fund ICIJ have programs or campaigns advocating for reform of the pharmaceutical ...

Merck is eyeing a quick review for its lipid-lowering drug candidate enlicitide, which in December was awarded a Commissioner ...

March 30 (Reuters) - Merck's oral drug reduced bad cholesterol by up to 64.6% in a late-stage trial, the drugmaker said on Monday, as it looks for its next blockbuster candidate. Merck's non-statin ...

The pharmaceutical giant is a standout performer within the health-care sector, and the stock could be poised for a big jump.

By Christy Santhosh March 30 (Reuters) - Drugmaker Merck said on Monday its oral drug met the main goal of meaningfully ...

Merck's $6.7 billion Terns acquisition bolsters its oncology pipeline while reinforcing its strong margins, steadily growing ...

In an R&D collaboration worth as much as $838 million, Merck will lean on Infinimmune to discover immune cell-directed ...

Merck Foundation declared Gabon First Lady as Ambassador of “More than a Mother” to build healthcare capacity, break infertility stigma, and support girl education ...